# GE Healthcare expands API facility in Lindesnes, Norway for $80M

GE Healthcare is investing $80 million to expand its active pharmaceutical ingredient manufacturing facility in Lindesnes, Norway, increasing contrast media production capacity by 30% and creating approximately 100 jobs. The expansion aims to add 30 million patient doses per year by 2025.

- Type: Expansion
- Announced: 2023-05-19
- Where: Lindesnes, Norway, Norway
- Value: $80.0M
- Jobs: 100
- Starts operating: 2025
- Status: announced
- Capacity: 30 million patient doses per year
- Products: iodinated contrast media, active pharmaceutical ingredients
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [GE Healthcare](https://endata.com/companies/4246.md)

## Sources

- [pharmaceutical-technology.com](https://www.pharmaceutical-technology.com/projects/ge-healthcares-api-facility-expansion-lindesnes-norway/), 2023-05-19: "GE Healthcare is investing $80m in the expansion of the facility."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.